Ashish Tripathi
Directeur/Bestuurslid bij Epigeneres Biotech Pvt Ltd.
Profiel
Ashish Tripathi has worked as a Director at Epigeneres Biotech Pvt Ltd since 2016.
Actieve functies van Ashish Tripathi
Bedrijven | Functie | Begin |
---|---|---|
Epigeneres Biotech Pvt Ltd.
Epigeneres Biotech Pvt Ltd. Pharmaceuticals: MajorHealth Technology Epigeneres Biotech Pvt Ltd. is an Indian company that focuses on detecting and treating cancer early. The company is based in Mumbai, India and was founded in 2012 by Anish Tripathi. In addition to their cancer detection technology, they also have a nutraceuticals business that specializes in molecular diagnostics and nutraceutical management for overall health and well-being. The company has developed a breakthrough technology based on the assumption that very small embryonic-like stem cells (VSELs) undergo epigenetic changes and get transformed into cancer stem cells (CSCs). The company's HRC test has the potential to detect cancer at stage zero, which significantly improves the cost, time, and chances of survival. | Directeur/Bestuurslid | 29-02-2016 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Epigeneres Biotech Pvt Ltd.
Epigeneres Biotech Pvt Ltd. Pharmaceuticals: MajorHealth Technology Epigeneres Biotech Pvt Ltd. is an Indian company that focuses on detecting and treating cancer early. The company is based in Mumbai, India and was founded in 2012 by Anish Tripathi. In addition to their cancer detection technology, they also have a nutraceuticals business that specializes in molecular diagnostics and nutraceutical management for overall health and well-being. The company has developed a breakthrough technology based on the assumption that very small embryonic-like stem cells (VSELs) undergo epigenetic changes and get transformed into cancer stem cells (CSCs). The company's HRC test has the potential to detect cancer at stage zero, which significantly improves the cost, time, and chances of survival. | Health Technology |